Literature DB >> 25084449

Comparison of outcome and side effects between conventional and transvaginal laparoscopic cholecystectomy: a meta-analysis.

Jian Xu1, Liang Xu, Lintao Li, Siluo Zha, Zhiqian Hu.   

Abstract

Transvaginal laparoscopic cholecystectomy (TVC) is becoming an attractive alternative to conventional laparoscopic cholecystectomy (CLC). We conducted a meta-analysis study to compare the outcome and side effects between TVC and CLC. Clinical studies on TVC with CLC as control were identified by searching PubMed and EMBASE (from 2007 to December 2013). Nine studies were identified for meta-analysis. Our results showed that TVC required much longer operative time [MD, 30.82; 95% confidence interval (CI), 13.00-48.65; P=0.0007] and had significantly lower pain score on postoperative day 1 as compared with CLC (MD, -1.77; 95% CI, -2.91 to -0.63; P=0.002). No statistical difference in days of hospital stay (MD, -1.60; 95% CI, -4.73 to 1.54; P=0.32) and number of complications was found between the 2 groups (risk ratio, 0.52; 95% CI, 0.25-1.10; P=0.09). Safety of TVC is similar as CLC. In conclusion, TVC patients have significantly less postoperative pain but need much longer operative time.

Entities:  

Mesh:

Year:  2014        PMID: 25084449     DOI: 10.1097/SLE.0000000000000066

Source DB:  PubMed          Journal:  Surg Laparosc Endosc Percutan Tech        ISSN: 1530-4515            Impact factor:   1.719


  2 in total

1.  [Operation time for suprapubic transumbilical cholecystectomy: Results of a prospective randomized trial].

Authors:  J Hipp; J Laniewski; E Gitei; S Elhabash; O Akkermann; B Gerdes
Journal:  Chirurg       Date:  2015-09       Impact factor: 0.955

2.  Does obesity influence the results in Transvaginal Hybrid-NOTES cholecystectomy?

Authors:  Dirk R Bulian; Jurgen Knuth; Panagiotis Thomaidis; Anna Rieger; Claudia Simone Seefeldt; Jonas Lange; Jurgen Meyer; Michael A Stroehlein; Markus M Heiss
Journal:  Surg Endosc       Date:  2018-05-16       Impact factor: 4.584

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.